NCT03860272 2026-03-30Fc-Engineered Anti-CTLA-4 Monoclonal Antibody in Advanced CancerAgenus Inc.Phase 1 Active not recruiting499 enrolled
NCT06440005 2026-02-11A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid TumorsAngiex, Inc.Phase 1 Recruiting80 enrolled
NCT05826600 2026-01-06A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed SurgicallyiOmx Therapeutics AGPhase 1/2 Active not recruiting188 enrolled
NCT02625389 2025-10-10A Study to Evaluate How Safe and Effective is the Mixture of Lipiodol® Ultra Fluid and Glue When Used for Embolization ProceduresGuerbetPhase 4 Completed132 enrolled 9 charts
NCT06277154 2025-07-24MASCT-I Combined With Doxorubicin and Ifosfamide for First-line Treatment of Advanced Soft Tissue SarcomaHRYZ Biotech Co.Phase 2 Recruiting148 enrolled